Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial”.
Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein +18 more
Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne‐Sophie Michallet +12 more
A. Italiano, Paola Romano, P.A. Cassier, L.L. Siu, I.S. Lossos +15 more